Last updated: February 12, 2020
Sponsor: Chongqing Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congestive Heart Failure
Chest Pain
Hyponatremia
Treatment
N/AClinical Study ID
NCT04269057
2019-10
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
left ventricular ejection fraction ≥50%;
with the symptoms and/or signs of heart failure;
BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL;
at least one additional criterion: relevant structural heart disease(LVH and/or LAE)or diastolic dysfunction.
Exclusion
Exclusion Criteria:
LVEF less than 45% at any time;
severe infection;
ACS;
pregnancy;
eGFR <30 mL/min/1.73 m2, etc.
Study Design
Total Participants: 90
Study Start date:
October 01, 2019
Estimated Completion Date:
October 01, 2020
Study Description
Connect with a study center
The First Affiliated Hospital of Chongqing Medical University
Chongqing,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.